NBIX vs VNRX · P/E 45, rev $1.77B vs rev $1.4M
Neurocrine Biosciences Inc (NBIX) versus Volitionrx Ltd (VNRX) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Volitionrx Ltd (VNRX) is a medical devices company listed on AMEX.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported VNRX revenue for 2026-06-30 was $1.4M. Net income was -$14.0M. Revenue was up 40.5% from 2026-03-31 to 2026-06-30. VNRX currently screens at market cap $15.9M.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. VNRX currently screens at market cap $15.9M.
Not investment advice. Open the NBIX and VNRX stock pages for the full models.
Not investment advice.